Cuscutamine

CAS No. 122170-93-8

Cuscutamine( —— )

Catalog No. M32267 CAS No. 122170-93-8

Cuscutamine has luciferase-inducing activity and can significantly stimulate cancer cell proliferation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cuscutamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Cuscutamine has luciferase-inducing activity and can significantly stimulate cancer cell proliferation.
  • Description
    Cuscutamine has luciferase-inducing activity and can significantly stimulate cancer cell proliferation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    122170-93-8
  • Formula Weight
    270.3
  • Molecular Formula
    C15H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Planta Med . 2004 Apr;70(4):299-304.
molnova catalog
related products
  • Obtustatin

    Highly potent integrin α1β1 inhibitor (IC50 = 0.8 nM for α1β1 binding to type IV collagen). Selective for α1β1 over α2β1, αIIbβ3, αvβ3, α4β1, α5β6, α9β1 and α4β7. Inhibits FGF2-stimulated angiogenesis in the chicken chorioallantoic model. Displays antitumor efficacy in a synergistic mouse model of Lewis lung carcinoma; blocks human melanoma growth in nude mice.

  • Isomagnolone

    Isomagnolone is a natural product isolated from Illicium burmanicum and has anti-inflammatory activity.

  • Negletein

    Negletein has anti-inflammatory and immunomodulatory activities via inhibition of TNF-α, iNOS and IL-1β.